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To maintain organismal homeostasis, phagocytes engulf dead cells, which are recognized as 
dead by virtue of a characteristic “eat me” signal exposed on their surface. The dead cells are 
then transferred to lysosomes, where their cellular components are degraded for reuse. Inefficient 
engulfment of dead cells activates the immune system, causing disease such as systemic lupus 
erythematosus, and if the DNA of the dead cells is not properly degraded, the innate immune 
response becomes activated, leading to severe anemia and chronic arthritis. Here, we discuss how 
the endogenous components of dead cells activate the immune system through both extracellular 
and intracellular pathways.Introduction
In the Japanese movie Departures (Okuribito in Japanese), 
which won the 2009 Oscar for best foreign language film, 
death is regarded as a gate. The deceased are gently washed, 
dressed, and placed in a coffin for departure into the next life. 
Similarly, when the cells in our bodies die, an elaborate pro-
cess takes place to remove them and to give them a new life by 
using their components.
Many extra cells are generated and die during animal devel-
opment. In human adults, billions of cells die every day as part 
of the body’s natural processes. Cells that become damaged by 
microbial infection or mechanical stress also die. The cell death 
that occurs in the physiological setting is programmed, and is 
therefore called programmed cell death (Lockshin and Zakeri, 
2001). Apoptosis is the major death process, but necrosis and 
autophagic cell death have also been proposed to play roles 
in programmed cell death (Kroemer et al., 2009). Dying cells 
secrete a “find me” signal, and they expose an “eat me” signal on 
their surface. In response to the “find me” signal, macrophages 
approach the dead cells; they then recognize the “eat me” sig-
nal (Ravichandran and Lorenz, 2007). Using sophisticated cell 
machinery, the phagocytes ingest the dead cells, direct them 
to lysosomes, and degrade their cellular components into basic 
biochemical building blocks: amino acids, nucleotides, fatty 
acids, and monosaccharides. These molecules will be released 
from the lysosomes and reused to make new macromolecules. 
In definitive erythropoiesis, the process by which red blood cells 
are generated, the nuclei are extruded from erythroid precur-
sor cells at the final differentiation stage and are engulfed by 
macrophages (Chasis and Mohandas, 2008). The machinery 
used for the engulfment and degradation of the extruded nuclei 
appears similar to that used for the removal of apoptotic cells.
Mice deficient in the engulfment of apoptotic cells develop 
systemic lupus erythematosus (SLE)-type autoimmune dis-
eases (Hanayama et al., 2004). A defect in the degradation of Cell 140, March 5, 2010 ©2010 Elsevier Inc. 619
the chromosomal DNA from engulfed cells in mice activates 
macrophages, leading to lethal anemia in embryos and chronic 
arthritis in adults (Kawane et al., 2001; Kawane et al., 2006). 
These observations indicate that dead cells and the nuclei 
expelled from erythroid precursor cells need to be swiftly 
cleared for animals to maintain homeostasis.
Programmed Cell Death
Based on morphological and biochemical criteria, four differ-
ent cell-death processes (apoptosis, cornification, necrosis, 
and autophagy) have been officially proposed (Kroemer et al., 
2009). In apoptosis, the cell and nuclei condense and become 
fragmented and are engulfed by phagocytes (Kerr et al., 1972). 
Apoptosis is regulated by gene products, and programmed 
cell death has often been used synonymously with apoptosis. 
However, necrosis is also regulated by gene products (Cho et 
al., 2009; He et al., 2009), and it may be preferable to use the 
term programmed cell death in only its more general sense, 
that is, to refer to any cell-death process that is programmed 
into animal development.
It is unclear to what extent the other proposed forms of 
cell death can be classified as programmed cell death. Of 
them, autophagy, in which organelles and macromolecules 
are trapped by the cell’s own membranes and degraded in its 
lysosomes, is a process by which cells survive in starvation 
conditions (Ohsumi, 2001). Autophagy has been proposed 
as a cell-death process because cells undergoing severe or 
prolonged autophagy may die, and dying cells often show a 
characteristic, autophagic morphology (Tsujimoto and Shi-
mizu, 2005). However, there are no convincing data support-
ing the notion that autophagy kills the cells, and hence the 
term autophagic cell death may be misleading (Kroemer and 
Levine, 2008). Cornification, a cell-differentiation process, 
describes the cell death that occurs at the final step in the 
natural differentiation of skin cells (Lippens et al., 2005). Simi-
larly, the differentiation of the lens epithelial cells of the eye to 
fiber cells is accompanied by the degradation of nuclei, mito-
chondria, and endoplasmic reticulum (Bassnett, 2002), which 
can also be regarded as a cell-death process. However, it may 
not be appropriate to classify this cell-differentiation process 
as programmed cell death. In addition, although necrosis is 
mediated by gene products, it occurs only when apoptosis 
is blocked or when cells receive strong death signals under 
pathological conditions. Thus, we believe that apoptosis 
accounts for most of the physiological cell death during ani-
mal development and in the cell turnover that occurs daily.
Apoptosis
Apoptosis is activated by two pathways, the intrinsic and extrin-
sic pathways (Ow et al., 2008). In the intrinsic pathway, which 
operates in developmentally controlled and genotoxic agent-
mediated apoptosis, BH3-only members of the Bcl-2 family 
are transcriptionally upregulated and stimulate the release of 
cytochrome C from the mitochondria. Together with Apaf-1, 
cytochrome C activates caspase 9, which leads to the activa-
tion of downstream caspases, including caspases 3 and 7. The 
antiapoptotic members of the Bcl-2 family inhibit the release 
of cytochrome C from mitochondria by a mechanism that has 
not been well elucidated. This intrinsic pathway is thought to 
be well conserved in metazoans, but its key step, the release 
of cytochrome C from mitochondria, is not observed in the 
nematode C. elegans or in the fruit fly Drosophila (Oberst et 
al., 2008).
Fas ligand (FasL), tumor necrosis factor (TNF), and TRAIL 
(TNF-related apoptosis-inducing ligand) are type II membrane 
proteins that can activate the extrinsic death pathway (Kram-
mer, 2000; Nagata, 1997; Strasser et al., 2009). The binding of 
FasL to its receptor (Fas) induces the formation of the death-
inducing signaling complex (DISC), consisting of Fas, an adap-
tor protein (FADD), and procaspase 8. Formation of the DISC 
leads to the processing and activation of caspase 8. Depending 
on the cell type, there are two pathways that can be activated 
downstream of caspase 8. In type I cells (for example, thymo-
cytes), caspase 8 directly activates caspase 3 to kill the cells; in 
type II cells (hepatocytes), caspase 8 cleaves Bid, a BH3-only 
member of the Bcl-2 family, and the cleaved Bid (tBid) induces 
the release of cytochrome C from the mitochondria, which 
leads to the activation of the caspase 9-caspase 3 pathway.
In both the intrinsic and extrinsic pathways, apoptosis is 
completed by the cleavage of a set of cellular proteins (more 
than 500 substrates) by effector caspases (caspases 3 and 7) 
(Lüthi and Martin, 2007; Timmer and Salvesen, 2007) (http://
cutdb.burnham.org/; http://bioinf.gen.tcd.ie/casbah/). The 
massive protein cleavage is probably responsible for the mor-
phological and biochemical changes that occur during apop-
tosis, and for killing the cells. However, with a few exceptions 
(see below), the physiological meaning of the specific cleavage 
events is not clear. In addition to killing the cells, caspase acti-
vation is involved in the cells’ production of the “find me” and 
“eat me” signals sensed by phagocytes.
Apoptotic DNA Degradation and Membrane Blebbing
One of notable hallmarks of apoptosis is DNA fragmentation, 
the cleavage of chromosomal DNA into 180 bp nucleosomal 
units (Wyllie, 1980). This process, accomplished by CAD 620 Cell 140, March 5, 2010 ©2010 Elsevier Inc.(caspase-activated DNase), also called DFF-40 (DNA frag-
mentation factor 40), is the most representative example of 
how caspase activation causes a characteristic feature of 
apoptosis (Enari et al., 1998; Liu et al., 1997). In healthy cells, 
CAD is complexed with its inhibitor, ICAD (inhibitor of CAD), 
also called DFF-45 (Enari et al., 1998; Liu et al., 1997; Saka-
hira et al., 1998), which also acts as a chaperone for CAD to 
ensure its correct folding (Sakahira et al., 2000). Caspase 3 
cleaves ICAD at two positions (Sakahira et al., 1998), which 
allows CAD to form a homodimer that has a scissor-like 
structure (Woo et al., 2004). CAD carries a nuclear-local-
ization signal and cleaves DNA in the nucleus via specific 
histidine residues (Sakahira et al., 2001) located in the deep 
cleft between the “blades” of the “scissors.” This structure 
prevents CAD from accessing the DNA on nucleosomes, but 
allows it access to DNA in the spacer regions between them, 
which explains why the chromosomal DNA is degraded into 
nucleosomal units during apoptotic cell death. CAD gener-
ates DNA fragments with a 3′-hydroxyl group. This group 
is identified by TUNEL (terminal transferase-mediated 
dUTP nick end labeling) staining, which is widely used to 
detect apoptotic cells in vitro and in vivo. At the early stage 
of apoptosis, DNA is degraded into relatively large pieces 
(50–200 kb). Endonucleases other than CAD have been 
postulated to perform this cleavage (Samejima et al., 2001; 
Susin et al., 2000). However, at least in our hands, no DNA 
degradation (whether to high-molecular-weight fragments 
or nucleosomal units) can be observed in cells lacking CAD 
(Kawane et al., 2003), indicating that other nucleases are not 
involved or play only a limited role.
Caspase cleavage also explains another hallmark of apop-
totis, membrane blebbing. ROCK1 (Rho-associated kinase 1), 
a substrate of caspase 3, phosphorylates various cytoskel-
etal proteins, including myosin light chain, and regulates 
the actin cytoskeleton. ROCK1 is normally regulated by Rho 
GTPase, but its cleavage by caspase 3 removes its regulatory 
domain and renders it constitutively active (Coleman et al., 
2001; Sebbagh et al., 2001). This aberrantly activated ROCK1 
intensively phosphorylates myosin light chain, leading to 
membrane blebbing.
The microinjection of active CAD into cells causes DNA 
fragmentation and quickly kills the cells (Susin et al., 2000). 
In contrast, CAD-deficient cells are efficiently killed by apop-
totic stimuli without DNA degradation (Kawane et al., 2003). 
As described above, given that many proteins and enzymes 
essential for cell survival are cleaved and inactivated by cas-
pases, it is likely that once caspases are activated by apoptotic 
stimuli, there are many ways to kill the cells.
Engulfment of Apoptotic Cells
When apoptotic cells are left on a Petri dish for a long time, 
their plasma membrane ruptures and cellular contents are 
released, in a process called secondary necrosis (Kerr et 
al., 1972). On the other hand, apoptotic cells in vivo are 
quickly recognized by phagocytes and engulfed to pre-
vent the release of their intracellular materials, which can 
be immunogenic. For the specific and efficient engulfment 
of apoptotic cells, the dead cells discharge molecules to 
recruit phagocytes (“find me” signals), and they expose on 
their surface molecules that are recognized by phagocytes 
(“eat me” signals) (Figure 1).
“Find Me” Signals
By assaying the ability of the culture supernatant from apop-
totic cells to trigger the chemotaxis of macrophages, Lauber 
et al. (2003) identified lysophosphatidylcholine (LPC) as a 
“find me” signal (Figure 2). It is released from apoptotic cells 
by the caspase-3-dependent activation of phospholipase 
A2, which converts phosphatidylcholine to LPC. The bind-
ing of LPC to G2A (G2 accumulation protein or G protein-
coupled receptor 132) activates macrophages to undergo 
chemotaxis (Peter et al., 2008). This model is attractive, but 
the concentration of LPC required to cause the chemotaxis 
of phagocytes is rather high (20–30 µM) and may not be 
reached physiologically.
Two other molecules, sphingosine-1-phosphate (S1P) and 
CX3CL1/fractalkine, have also been proposed to act as “find 
me” signals (Gude et al., 2008; Truman et al., 2008). S1P is pro-
duced by sphingosine kinase in a caspase-dependent manner 
and secreted from apoptotic cells; it stimulates the chemot-
axis of macrophages by binding its specific receptor, S1P-R. 
Fractalkine, CX3CL1, is synthesized as a membrane-associ-
ated protein, rapidly processed, and released from apoptotic 
neurons or B cells. It activates microglia and macrophages to 
undergo chemotaxis by binding to its receptor, CX3CR. In addi-
tion, ATP and UTP released from apoptotic cells in a caspase-
dependent manner have recently been shown to act as “find 
Figure 1. Engulfment of Apoptotic Cells by Macrophages
When cells undergo apoptosis, they release “find me” signals to recruit mac-
rophages, and expose “eat me” signals on their surface. In response to the 
“find me” signal, macrophages approach the dead cells, and they engulf them 
by recognizing the “eat me” signal. The engulfed dead cells are transferred to 
lysosomes, where all their components are degraded into amino acids, nucle-
otides, fatty acids, and monosaccharides by lysosomal enzymes.me” signals for apoptotic cells (Elliott et al., 2009). Whether 
these proposed “find me” signals are redundant, additive, or 
synergistic remains to be studied.
Apoptotic cells appear to mostly (or exclusively) recruit mac-
rophages (Truman et al., 2004). Yet, the proposed molecules 
(LPC, S1P, and ATP/UTP) activate not only macrophages but 
also neutrophils and lymphocytes (Florey and Haskard, 2009; 
Lecut et al., 2009). Bournazou et al. (2009) propose that lacto-
ferrin is synthesized in apoptotic cells, secreted, and inhibits 
the migration of neutrophils. However, this may not be consis-
tent with the quick killing of the death-factor-induced apopto-
sis that does not require protein synthesis. An involvement of 
lactoferrin in the “find me” process should be clarified with the 
lactoferrin-deficient mice (Ward et al., 2003).
“Eat Me” Signals
Macrophages engulf dead cells but not healthy ones, indicating 
either that dying cells expose “eat me” signals recognized by 
phagocytes or that healthy cells display “don’t eat me” signals. 
The best-studied “eat me” signal is phosphatidylserine, a com-
ponent of the cell plasma membrane that is kept exclusively 
on the inner leaflet of the lipid bilayer in healthy cells (Balasu-
bramanian and Schroit, 2003). Phosphatidylserine is exposed 
on the cell surface when cells undergo apoptosis (Fadok et al., 
1992). Moreover, when phosphatidylserine is inserted into the 
plasma membrane of erythrocytes, they are recognized and 
engulfed by macrophages (Tanaka and Schroit, 1983). Further-
more, the masking of phosphatidylserine inhibits the engulf-
ment of apoptotic cells in vitro and in vivo (Asano et al., 2004; 
Krahling et al., 1999). These results strongly point to phosphati-
dylserine as the most likely candidate for the “eat me” signal.
The exposure of phosphatidylserine on the surface of apop-
totic cells is found not only in mammals but also in Drosophila 
and C. elegans (van den Eijnde et al., 1998; Venegas and Zhou, 
Figure 2. Proposed “Find Me” Signals
As “find me” signals, ATP/UTP, lysophosphatidylcholine (LPC), sphingosine-
1-phosphate (S1P), and fractalkine CX3CL1 have been proposed. These mol-
ecules bind specific receptors on macrophages, all of which are G protein-
coupled seven-transmembrane receptors, and activate them for chemotaxis.Cell 140, March 5, 2010 ©2010 Elsevier Inc. 621
2007). This process is caspase dependent (Martin et al., 1996), 
but how caspase activity leads to the cell-surface exposure of 
phosphatidylserine remains unsettled (Schlegel and William-
son, 2007). In one model, ATP-dependent translocases that 
maintain phosphatidylserine at the inner leaflet of the plasma 
membrane are inactivated in apoptotic cells, but Ca2+-depen-
dent phospholipid scamblase is activated, causing randomiza-
tion of the membrane leaflet components (Balasubramanian 
and Schroit, 2003; Sahu et al., 2007). This model has been 
examined in mammals and C. elegans, but with controversial 
results (Darland-Ransom et al., 2008; Züllig et al., 2007).
CD47, also called integrin-associated protein (IAP), is a 
membrane protein with five membrane-spanning regions. 
When CD47-deficient red blood cells are injected into mice, 
they are more rapidly cleared by macrophages in the spleen 
than are CD47-positive cells. Oldenborg et al. (2000) therefore 
proposed that CD47 serves as a “don’t eat me” signal. How-
ever, when CD47-positive red blood cells are loaded with phos-
phatidylserine, they are efficiently engulfed by macrophages 
(Tanaka and Schroit, 1983). Thymocytes express abundant 
CD47. When they undergo apoptosis, their CD47 expression 
is not lost, yet the apoptotic thymocytes are still efficiently 
engulfed by macrophages (Tada et al., 2003). These observa-
tions indicate that the “eat me” signal can overcome the “don’t 
eat me” signal.
Bridging Molecules that Recognize Phosphatidylserine
Several secreted proteins have been identified as molecules 
that recognize the phosphatidylserine on apoptotic cells and 
promote their engulfment (Figure 3). Milk fat globule EGF 
factor 8 (MFG-E8), originally found associated with milk fat 
globules in mammary glands, is a secreted protein present 
Figure 3. Molecules Proposed to Recognize Phosphatidylserine
The most likely “eat me” signal is phosphatidylserine. MFG-E8 and Gas6 are 
secreted proteins that bind phosphatidylserine and work as bridging mole-
cules between apoptotic cells and macrophages. Tim-4, BAI1, and Stabilin-2 
are type I-membrane proteins that are proposed phosphatidylserine recep-
tors. Molecules that activate Rac1 (CrkII, Dock180, Elmo, and GULP) are in-
volved in the engulfment of apoptotic cells.622 Cell 140, March 5, 2010 ©2010 Elsevier Inc.on a subset of phagocytes that actively engulf apoptotic cells 
(Hanayama et al., 2002). It is expressed by macrophages 
and immature dendritic cells, including tingible-body mac-
rophages and follicular dendritic cells at the germinal centers 
in the spleen and lymph nodes, thioglycollate-elicited perito-
neal macrophages, granulocyte-macrophage colony stimulat-
ing factor (GM-CSF)-induced bone marrow-derived immature 
dendritic cells, and Langerhans cells in the skin (Hanayama et 
al., 2004; Kranich et al., 2008; Miyasaka et al., 2004). MFG-E8 
contains one (human) or two (mouse) epidermal growth fac-
tor (EGF) domains in its N-terminal half, with the human and 
second mouse EGF domain carrying an RGD (Arg-Gly-Asp) 
motif. It has two factor-VIII-homologous domains (C1 and C2) 
in its C-terminal region. MFG-E8 associates with αvβ3 or αvβ5 
integrin on phagocytes via its RGD motif (Yamaguchi et al., 
2008), binds tightly to phosphatidylserine through its C1 and 
C2 domains, and stimulates the engulfment of apoptotic cells 
(Hanayama et al., 2002).
Two related proteins, growth arrest-specific 6 (Gas6) and 
protein S, which are abundant in plasma, bind phosphatidylser-
ine (Nakano et al., 1997). TAM family members (Tyro3, Axl, and 
Mer), which are tyrosine-kinase receptors, are the receptors 
for Gas6 and protein S. Gas6 and protein S are involved in the 
vitamin K-dependent clotting system, and a deficiency in Gas6 
or its receptor causes platelet dysfunction (Angelillo-Scherrer 
et al., 2005; Angelillo-Scherrer et al., 2001). On the other hand, 
mice expressing a kinase-dead mutant of Mer (MerKD) develop 
SLE-like autoimmunity (Scott et al., 2001), and the Gas6-TAM 
system has been proposed to play a role in the engulfment 
of apoptotic cells, particularly in the testis and retina (Prasad 
et al., 2006; Xiong et al., 2008). A recent report indicates that 
TAM receptors negatively regulate the innate immune reaction, 
and a lack of TAM receptors causes dendritic cells to overpro-
duce interleukin-6 (IL-6), interferon (IFN), and TNFα (Rothlin et 
al., 2007). Given that SLE-type autoimmunity is regulated by 
cytokines, this overproduction of cytokines by dendritic cells 
might be responsible for the SLE-like autoimmunity found in 
the MERKD mice (Scott et al., 2001).
Phosphatidylserine Receptors
Whether macrophages directly recognize apoptotic cells has 
been difficult to elucidate. A protein initially identified by Fadok 
et al. (2000) as a phosphatidylserine receptor (and conse-
quently named PSR) is now reported to have a different func-
tion. Fadok et al. identified PSR by screening a phage-display 
library with a monoclonal antibody that inhibits the engulf-
ment of apoptotic cells. Several groups subsequently reported 
that the deficiency of PSR causes the impaired engulfment of 
apoptotic cells, resulting in embryonic lethality in the mouse 
(Kunisaki et al., 2004; Li et al., 2003) and delayed engulfment 
of apoptotic cells in C. elegans (Wang et al., 2003). In contrast, 
Böse et al. (2004) who independently established PSR knock-
out mice, reported that PSR is not the protein recognized by 
the monoclonal antibody used by Fadok et al., and that PSR 
null macrophages have no defect in the engulfment of apop-
totic cells. Subsequent reports have indicated that PSR is a 
chromatin-remodeling factor called Jumonji domain-contain-
ing 6 protein (JMJD6), which is present in the nucleus (Chang et 
al., 2007). Hence, the increased number of unengulfed apop-
Table 1. Molecules Involved in the Engulfment of Apoptotic Cells
C. elegans Mammalian Properties
CED-1 MEGF10 Type I membrane protein with multiple epidermal growth factor (EGF)-like domains in the extracellular region
CED-2 CrkII Cytoplasmic protein with a Src homology 2 (SH2) and an SH3 domain, that functions as an adaptor for signal 
transduction
CED-5 Dock180 Cytoplasmic protein containing an SH3 domain; it associates with CrkII and ELMO, and activates the Rho family 
GTPase Rac1 as a guanine exchange factor
CED-6 GULP Cytoplasmic protein with a phosphotyrosine-binding domain (PTB) and four SH3-binding motifs; it binds to 
CED-1 and functions upstream of CED-10
CED-7 ABC transporter Protein with two homologous repeats, each harboring six transmembrane segments and one ATP-binding site
CED-10 Rac1 Small GTP-binding protein of the Ras superfamily
CED-12 ELMO Cytoplasmic protein; it associates with CrkII and Dock180, and activates Rac1totic cells in the animals lacking PSR may be due to increased 
cell death caused by the lack of JMJD6’s chromatin remodel-
ing function.
In investigating the mechanism by which macrophages that 
do not express MFG-E8 engulf apoptotic cells, we reported 
that type I membrane proteins called T cell immunoglobulin- 
and mucin-domain-containing molecule 4 (Tim-4) and Tim-1 
serve as phosphatidylserine receptors (Miyanishi et al., 2007) 
(Figure 3). Tim-1 and Tim-4 consist of a signal sequence, an 
immunoglobulin V (IgV) domain, a mucin-like domain, a trans-
membrane domain, and a cytoplasmic region. They specifically 
bind phosphatidylserine with high affinity via their IgV domain. 
When Tim-1 or Tim-4 is expressed in mouse fibroblasts (NIH 
3T3), which do not normally express Tim family members, 
the transformants efficiently engulf apoptotic cells. The short 
cytoplasmic region of Tim-4 is dispensable for the engulfment 
(Park et al., 2009) (M. Murai, M. Miyanishi, and S.N., unpub-
lished data), indicating that Tim-4 associates with endog-
enous molecules on the fibroblast membrane to activate the 
engulfment signal. Among other Tim family members, Tim-3 
also binds phosphatidylserine and stimulates the engulfment 
of apoptotic cells, although with less efficiency than Tim-1 or 
Tim-4 (Nakayama et al., 2009).
Tim-4 is expressed by macrophages and dendritic cells 
in the spleen, lymph nodes, thymus, and tonsils (Shakhov et 
al., 2004), and Tim-3 is expressed in CD8+ dendritic cells in 
the spleen (Nakayama et al., 2009). These macrophages and 
dendritic cells are responsible for the engulfment of apop-
totic cells and for the presentation of dead cell-associated 
antigens (Miyake et al., 2007). Tim-1, also called kidney injury 
molecule 1 (Kim-1), is expressed in kidney epithelial cells after 
ischemic injury (Ichimura et al., 2008) and in Th2 cells (Umetsu 
et al., 2005). In the kidney, Tim-1 is likely to be responsible 
for engulfing the damaged apoptotic or necrotic cell debris 
generated during ischemic injury, but the role of Tim-1 in 
Th2 cells is not clear. The Tim family genes are clustered on 
human chromosome 5q33.2 and mouse chromosome 11B1.1, 
which is the susceptible gene locus for the development of 
atopy (allergic hypersensitivity) and asthma (Kuchroo et al., 
2003). Whether the newly identified function of Tim-1, Tim-3, 
and Tim-4 in apoptotic cell engulfment or the originally pro-
posed function of Tim-1 and Tim-4 in the costimulation of T 
cells (Kuchroo et al., 2003) is responsible for this phenotype 
remains to be studied.Park et al. (2007) report that brain-specific angiogenesis inhibi-
tor 1 (BAI1), a member of the secretin/vasoactive intestinal poly-
peptide (VIP) receptor family with 7-transmembrane regions, is 
another potential phosphatidylserine receptor for apoptotic cells. 
BAI1 binds via thrombospondin type 1 repeats (TSPs) to phos-
phatidylserine, as well as to cardiolipin and other phospholipids. Its 
cytoplasmic region can interact with the signal transducer ELMO 
(see below) (Park et al., 2007). However, BAI1’s possible function 
as a phosphatidylserine receptor for apoptotic cells seems to 
conflict with its neuron-specific expression in the brain (Mori et 
al., 2002). Another candidate phosphatidylserine receptor is sta-
bilin-2, also called HARE (hyaluronic acid receptor for endocyto-
sis), a type I membrane protein that carries a large extracellular 
region with seven fasciclin domains and fifteen EGF-like domains 
(Park et al., 2008). It is expressed by the sinusoidal endothelial 
cells of the spleen, lymph nodes, and bone marrow (Nonaka et 
al., 2007) and functions as a receptor for hyaluronic acids and 
heparin to regulate blood viscosity (Harris et al., 2008). How stabi-
lin-2 accomplishes two jobs, as a phosphatidylserine receptor for 
apoptotic cells and as a scavenger receptor for hyaluronic acids, 
would be an interesting topic for study.
Signaling Pathways for Engulfment
Genetic analyses in C. elegans identified seven genes that 
mediate the recognition and engulfment of apoptotic cells in 
two parallel and partially redundant signaling pathways (the 
CED-1/-6/-7 and CED-2/-5/-10/-12 pathways) (Table 1) (Red-
dien and Horvitz, 2004). CED-1 is a transmembrane receptor 
that has multiple EGF-like domains in its extracellular region; 
it has high homology with mammalian multiple EGF-like-
domains 10 (MEGF10) (Hamon et al., 2006) and may recog-
nize phosphatidylserine on apoptotic cells (Venegas and Zhou, 
2007). CED-6 is an ortholog of mammalian GULP (PTB [phos-
photyrosine-binding] domain-containing engulfment adaptor 
protein) and binds to the intracellular domain of CED-1 (Su et 
al., 2002). CED-7 is homologous to the ABC transporters that 
actively transport a variety of substances across the plasma 
membrane and was originally suggested to be responsible for 
exposing the “eat me” signal on apoptotic cells. However, the 
ABC transporter CED-7 interacts with MEGF10 (CED-1) (Hamon 
et al., 2006), indicating that it functions in the engulfment pro-
cess in phagocytes.
CED-2, -5, -10, and -12 correspond to mammalian CrkII, 
Dock180, Rac1, and ELMO1, respectively. CED-2/CrkII asso-
ciates with CED-5/Dock180, a guanine-nucleotide exchange Cell 140, March 5, 2010 ©2010 Elsevier Inc. 623
factor for CED-10/Rac1, and this interaction is positively regu-
lated by CED-12/ELMO1 (Côté and Vuori, 2007). This pathway 
regulates actin polymerization and is involved not only in apop-
totic-cell engulfment (Figure 3) but also in cell migration, neu-
rite growth, and myoblast fusion. Integrin family members may 
act upstream of this pathway, but how apoptotic cells activate 
this pathway remains to be determined.
The engulfment of apoptotic cells is regulated by Rho fam-
ily GTPases (Rac1, RhoA, Rab5, etc.) (Nakaya et al., 2006) and 
can be monitored at the molecular level by imaging using an 
actin-green fluorescent protein (GFP) fusion protein (Nakaya et 
al., 2008). This type of analysis indicates that the engulfment of 
apoptotic cells appears to occur at a limited number of portals 
in the phagocyte lamellipodia. A fluorescence resonance energy 
transfer (FRET) analysis for Rac1 indicates that the activation 
and deactivation of Rac1, controlled by “engulfment synapses,” 
must be regulated with specific timing for the efficient engulfment 
of apoptotic cells. That is, when a phagocyte starts to engulf an 
apoptotic cell, activated Rac1 and integrin are recruited to the 
portal and induce the formation of phagocytic cups consisting 
of an actin patch. As soon as the dead cell sinks into the phago-
cyte through one of these cups, Rac1 is inactivated and the actin 
is depolymerized. Subsequently, Rab5 regulates the transfer of 
the dead-cell cargoes into lysosomes (Kitano et al., 2008).
The uptake of apoptotic cells by phagocytes induces the 
expression of transforming growth factor β (TGFβ) and IL-10 
(Fadok et al., 2001) (Figure 4), which may inhibit the further recruit-
ment of macrophages to the dying cells. On the other hand, if the 
Figure 4. The Engulfment of Apoptotic versus Necrotic Cells
Macrophages engulfing apoptotic cells produce transforming growth factor 
β (TGFβ) and prostaglandin E2 (PGE2), which function as anti-inflammatory 
agents to inhibit the further recruitment of macrophages. When dead cells 
undergo secondary necrosis, the necrotic cells may activate macrophages 
through Fc receptor (FcR) and Toll-like receptors (TLRs) to produce inflamma-
tory cytokines, such as tumor necrosis factor α (TNFα) and interleukin 8 (IL-8), 
which act to recruit more macrophages.624 Cell 140, March 5, 2010 ©2010 Elsevier Inc.dead cells persist in tissues, either because of impaired engulf-
ment or because the number of apoptotic cells overwhelms the 
capacity of the phagocytes, the apoptotic cells undergo necrosis. 
When necrotic cells interact with or are engulfed by macrophages, 
the macrophages produce inflammatory cytokines (Fadok et al., 
2001), which may recruit more macrophages as reinforcements. 
The activation of different cytokine genes upon their engulfment 
of apoptotic and necrotic cells suggests that the signal transduc-
tion pathways induced by these dead cells are different.
Autoimmune Disease Caused by the Inefficient 
 Engulfment of Dead Cells
Systemic Lupus Erythematosus is a chronic autoimmune dis-
ease that causes a broad spectrum of clinical manifestations 
affecting the skin, kidney, lungs, blood vessels, and nervous 
system (D’Cruz et al., 2007). Patients with SLE have autoanti-
bodies in their sera against nuclear components (anti-ribonu-
cleoprotein and anti-DNA antibodies) and sometimes exhibit cir-
culating DNA or nucleosomes (Rumore and Steinman, 1990). As 
unengulfed apoptotic cells are present in the germinal centers of 
the lymph nodes of some SLE patients and macrophages from 
these patients often show a reduced ability to engulf apoptotic 
cells, a deficiency in the clearance of apoptotic cells is proposed 
to be one of the causes of SLE (Gaipl et al., 2006).
MFG-E8-deficient female mice, particularly of the B6/129-mixed 
background, develop an age-dependent SLE type of autoimmune 
disease (Hanayama et al., 2004). These mice produce high con-
centrations of anti-double-stranded DNA and anti-nuclear anti-
bodies and suffer from glomerular nephritis. When MFG-E8-defi-
cient mice are immunized with keyhole limpet hemocyanin (KLH) 
to activate B lymphocytes, many apoptotic cells are left unen-
gulfed on the tingible-body macrophages in the germinal centers, 
confirming that MFG-E8 has a nonredundant role in vivo in the 
engulfment of apoptotic cells by the tingible-body macrophages. 
It is likely that the unengulfed dead cells in MFG-E8-deficient mice 
undergo a secondary necrosis and release cellular components 
that activate the immune system to produce autoantibodies (Fig-
ure 5A). Like Fas-deficient lpr mice, in which autoreactive B cells 
are activated in a T cell-independent but Toll-like receptor (TLR)- 
and B cell receptor (BCR)-dependent mechanism (Herlands et al., 
2008), the released cellular components may activate autoreac-
tive B cells in a BCR- and TLR-dependent manner. This activa-
tion of autoreactive B cells may be further enhanced by cytok-
ines produced by macrophages in response to stimulation by the 
necrotic cells. In any case, the MFG-E8-deficient mice provide a 
good model system for studying the molecular mechanisms by 
which endogenous cellular components activate the immune sys-
tem extracellularly.
As described above, apoptotic cells are rapidly recognized and 
engulfed by macrophages at the early stage of their death pro-
cess, mostly in a phosphatidylserine-dependent manner. On the 
other hand, how necrotic cells are recognized and engulfed by 
macrophages is not well elucidated. One likely system for clear-
ing necrotic cells is the complement system (Trouw et al., 2008). 
C1q binds to dead cells at the later stages of apoptosis in an IgM-
dependent manner (Ogden et al., 2005), and one of the signals on 
the dead cells for IgM-binding is lysophosphatidylcholine (Kim et 
al., 2002). Notably, in humans, almost all individuals deficient in 
the C1q gene develop severe SLE (Botto and Walport, 2002). In 
C1q-deficient mice, unengulfed dead cells persist in the glomeruli 
of the kidneys, and the mice develop an SLE-like phenotype; this 
is particularly evident in the MRL/MP strain, which has a defect in 
the clearance of apoptotic cells (Potter et al., 2003). In this regard, 
the C1q-mediated engulfment may be a backup system for clear-
ing dead cells, and it may be informative to cross C1q-deficient 
mice with MFG-E8-deficient mice.
Degradation of Apoptotic Cells in Macrophages
Activation of the Innate Immunity by Undigested DNA 
Left in Lysosomes
After apoptotic cells are engulfed by phagocytes, all of their 
components are degraded into amino acids, nucleotides, 
fatty acids, and monosaccharides in lysosomes. As described 
above, the chromosomal DNA of the apoptotic cells is degraded 
cell autonomously into 180 bp nucleosomal units by CAD and 
then further degraded in the lysosomes of macrophages. The 
enzyme that degrades the DNA of apoptotic cells in lysosomes 
is DNase II (Kawane et al., 2003), which functions under acidic 
conditions (Evans and Aguilera, 2003). DNase II is ubiquitously 
expressed in various tissues, particularly in macrophages. 
A lack of DNase II causes the accumulation of 180 bp frag-
mented DNA in macrophages (Kawane et al., 2001) and acti-
vates the macrophages to produce various cytokines. One of 
the cytokines produced by these macrophages is IFNβ, which 
is cytotoxic to erythroblasts and lymphocytes (Yoshida et al., 
2005b) (Figure 5B).
Lethal Anemia and Polyarthritis 
Resulting from a Defect in DNA 
Degradation
Mice lacking DNase II die late in embryo-
genesis because of severe anemia 
(Kawane et al., 2001). Many TUNEL-pos-
itive erythroblasts can be found in the 
liver of mouse embryos lacking DNase II, 
and a deficiency in the IFN-type I recep-
tor gene rescues their lethality (Yoshida et al., 2005b), indicat-
ing that the erythroblasts are killed by the action of IFNβ. Mice 
with a double deficiency for DNase II and IFN-type I receptor, 
or mice in which the DNase II gene is deleted after birth via an 
inducible conditional knockout strategy, develop polyarthritis 
as they age (Kawane et al., 2006). Their swollen joints show 
severe synovitis with aggressive pannus formation. The pan-
nus carries osteoclasts at its leading edge, fills the joint cavity, 
erodes the cartilage, and destroys the bone. As in the joints of 
human rheumatoid arthritis patients, the genes for inflamma-
tory cytokines (IL-1β, IL-6, and TNFα) are strongly activated in 
the affected joints. Human patients with rheumatoid arthritis 
are successfully treated with reagents that antagonize TNFα or 
IL-6 (Feldmann, 2002; Yokota et al., 2008). Similarly, the admin-
istration of an anti-TNFα antibody significantly improves the 
clinical score for the polyarthritis developed by the DNase II 
null mice (Kawane et al., 2006).
What triggers the rheumatoid arthritis in humans is unknown. 
In the DNase II null mice, macrophages carrying undigested 
DNA express TNFα mRNA (Kawane et al., 2006), and a low, 
but significant, level of TNFα is found in the serum before the 
joints show any abnormality. Given that TNF-transgenic mice, 
which constitutively produce a low level of TNFα, develop pol-
yarthritis (Keffer et al., 1991), it is likely that the TNFα produced 
by the macrophages carrying undigested DNA is responsible 
for the development of the polyarthritis. Synovial cells respond 
to TNFα with high sensitivity to produce IL-1β and IL-6, which 
in turn stimulate the expression of the TNFα gene (Taberner et 
Figure 5. Immune System Activation by the 
Defective Engulfment of Apoptotic Cells
(A) Extracellular activation. If apoptotic cells are 
not swiftly engulfed, they undergo secondary ne-
crosis, in which the plasma membrane is disinte-
grated, and the cellular components are released. 
Immunoglobulins and complement proteins bind 
to these cellular components and activate mac-
rophages and B lymphocytes. In addition to FcR 
and B cell receptors (BCRs), Toll-like receptors 
(TLRs) appear to be involved in recognizing the 
cellular components and activating macrophages 
and B cells. The activated macrophages produce 
cytokines that will stimulate B cells to produce au-
toantibodies.
(B) Intracellular activation. After being engulfed by 
macrophages, dead cells are transferred to lyso-
somes and degraded. If the degradation does not 
occur properly, dead cell components accumulate 
in the lysosomes, leading to the intracellular ac-
tivation of the innate immune system to produce 
proinflammatory cytokines such as interferon β 
(IFNβ) and tumor necrosis factor α (TNFα).Cell 140, March 5, 2010 ©2010 Elsevier Inc. 625
al., 2005; Zhang et al., 2004), causing a “cytokine storm” in the 
joint. This leads to the growth of synovial cells, pannus forma-
tion, and the development of polyarthritis (Migita et al., 2001).
The pathologies (anemia and polyarthritis) caused by a defi-
ciency of DNase II are examples of lysosomal storage diseases, 
which are diseases caused by the inactivation or malfunction 
of lysosomal enzymes, including proteases, glycosidases, and 
lipases (Neufeld, 1991). Proteins, polysaccharides, DNA, and 
RNA of bacterial or viral origin activate the innate immunity 
to produce various cytokines (Uematsu and Akira, 2007). The 
results from the DNase II null mice indicate that mammalian DNA 
that accumulates in the lysosomes of macrophages also acti-
vates the innate immune response. Other cellular components 
that escape degradation in the lysosomes may also activate 
the TNFα and IFNβ genes. The fact that cytokines are constitu-
tively secreted by macrophages lacking lysosomal acid lipase 
(Lian et al., 2004), and by fibroblasts derived from patients with 
Niemann-Pick Disease Type C (Suzuki et al., 2007), an inherited 
lipid storage disorder, may support this notion. Some patients 
with rheumatoid arthritis can be cured by bone marrow trans-
plantation (Ikehara, 2002), suggesting that these patients have 
a defect(s) in bone-marrow-derived cells. Determining whether 
these patients have lysosomal enzyme defects will be useful 
for improving their treatment.
Signaling from DNA to Cytokine Gene Expression
Cells that are infected by viruses or bacteria normally produce 
IFNβ and TNFα (Honda et al., 2006). There are two pathways 
by which pathogens activate the cytokine genes. In one, TLR 
recognizes pathogens extracellularly and transduces signals 
via the adaptor proteins MyD88 and TRIF to activate the tran-
Figure 6. Engulfment of the Nuclei Expelled from Erythroid 
 Precursor Cells
At the final stage of definitive erythropoiesis, an erythroblast undergoes un-
equal division into a reticulocyte and a nucleus surrounded by plasma mem-
brane. Like apoptotic cells, the plasma membrane surrounding the nucleus 
exposes phosphatidylserine as an “eat me” signal and is engulfed by mac-
rophages.626 Cell 140, March 5, 2010 ©2010 Elsevier Inc.scription factors IFN-regulatory factor (IRF)3/IRF7 and NF-κB, 
which induce IFNβ and TNFα. In the other pathway, RIG-I/
MDA5 recognizes intracellular pathogens and activates IRF3/
IRF7 and NF-κB via an adaptor called IPS-1. The expression of 
the IFNβ and TNFα genes in the macrophages lacking DNase 
II is not blocked by a deficiency in the TLR system, indicating 
that the mammalian DNA that accumulates in the lysosomes 
activates the innate immune system in a TLR-independent 
manner (Okabe et al., 2005). We recently found that mamma-
lian DNA in lysosomes activates TNFα and IFNβ gene expres-
sion through the system for intracellular pathogens and that 
this system can be regulated by Janus phosphatases called 
Eyes absent (Eya) (Okabe et al., 2009). Eya binds to IPS-1 and 
is involved not only in the mammalian DNA-mediated innate 
immune reaction but also in the virus-induced one, indicating 
that endogenous DNA and viruses intracellularly activate the 
innate immune response using a similar mechanism. Identifi-
cation of the targets of Eya’s phosphatase will contribute to 
the understanding how the intracellular pathogens activate 
innate immunity.
Engulfment and Degradation of Nuclei from Erythroid 
Precursors
Early in mammalian embryogenesis, red blood cells are pro-
duced in the yolk sac in a process called primitive erythropoi-
esis. Erythropoiesis then takes place in the fetal liver at later 
stages of embryogenesis and in the bone marrow after birth, 
and this process is called definitive erythropoiesis. Unlike the 
nucleated erythroid cells produced in the yolk sac, those pro-
duced in the fetal liver and bone marrow are enucleated. The 
definitive erythropoiesis in both the bone marrow and fetal liver 
takes place in anatomical units called erythroblastic islands. 
At the center of each island, there is a macrophage that sup-
ports the proliferation and differentiation of the erythroid pre-
cursor cells (Chasis and Mohandas, 2008). At the final stage 
of erythropoiesis, the erythroid cells autonomously undergo 
enucleation, and the expelled nuclei are engulfed by the central 
macrophage, suggesting that the expelled nuclei also expose 
an “eat me” signal on their surface (Figure 6).
The engulfment of expelled nuclei by macrophages has 
been shown to be phosphatidylserine dependent in experi-
ments using nuclei collected from cultured erythroid precursor 
cells that spontaneously undergo enucleation (Yoshida et al., 
2005a). Immediately after a nucleus is separated from its reticu-
locyte, phosphatidylserine is exposed on the outer leaflet of the 
plasma membrane surrounding the nucleus. It is likely that the 
plasma membrane cannot maintain its integrity because of a 
lack of ATP, because once separated from the reticulocyte, the 
nucleus loses its sources of new ATP (mitochondria and glyco-
lysis). It is not yet known what molecules in the macrophages 
of the fetal liver and bone marrow are involved in recognizing 
the phosphatidylserine on the nuclei and engulfing them.
Every day, 2 × 1011 new red blood cells are produced in a 
human adult, meaning that this number of nuclei needs to be 
phagocytosed. This is at least ten times the number of dead 
cells. If nuclei, which are highly immunogenic, are released 
into the circulation because of inefficient engulfment, they 
will activate the immune system. In DNase II-deficient mice, 
the macrophages at the erythroblastic islands in the fetal liver 
and bone marrow carry a number of undigested nuclei in their 
lysosomes, indicating that DNase II is responsible for degrad-
ing the DNA from the engulfed erythroblast nuclei (Kawane et 
al., 2001). This means that, each day, the DNA from 2 × 1011 
erythroblasts in a human adult, corresponding to about 1.0 g, 
is degraded by a single enzyme, DNase II, in macrophages. 
As described above for the DNA of dead cells, the inefficient 
digestion of the nuclear DNA from erythroid precursors can 
also cause severe inflammation.
Future Prospects
To combat bacterial and viral infection, mammals have devel-
oped a sophisticated immune system, which includes the 
acquired and innate immune systems. In the innate immune 
system, macrophages and dendritic cells recognize patho-
gens extracellularly and intracellularly and produce various 
cytokines such as IFNβ, IL-1β, and TNFα to contend with the 
pathogens directly. These cytokines also activate the acquired 
immune response to produce antibodies and cytotoxicity to 
combat the pathogens. Endogenous components derived 
from dead cells can also activate both the acquired and innate 
immune systems. Undigested DNA that accumulates in the lys-
osomes of macrophages can activate the intracellular signaling 
pathway for the innate immune reaction, while cellular compo-
nents released from dead cells appear to activate the immune 
reaction extracellularly, through the BCR and TLR system. The 
immune reaction triggered by bacterial and viral pathogens is 
transient; that is, when the bacteria or viruses are removed by 
the action of IFN or TNF, the immune reaction ceases. In con-
trast, if a defect in the engulfment or digestion of dead cells 
or erythroid nuclei is not repaired, the immune system will be 
chronically activated, which may be responsible for SLE-type 
autoimmune disease and polyarthritis, two major autoimmune 
diseases in humans. Our knowledge about how dead cells and 
the expelled erythroid nuclei are recognized, engulfed, trans-
ferred to lysosomes, and degraded is still very primitive. The 
elucidation of these processes will help us understand the 
pathophysiology of various human diseases, especially auto-
immune diseases, and will lead to the development of new 
therapeutic strategies for treating them.
Apoptotic-cell engulfment is phosphatidylserine depen-
dent. Other examples of phosphatidylserine-dependent pro-
cesses are the involution of mammary glands (Hanayama and 
Nagata, 2005) and the axon pruning that takes place during 
the development of neural circuits (Awasaki et al., 2006). In the 
involution of mammary glands, milk fat globules remaining in 
the mammary glands are re-absorbed by mammary epithelial 
cells in a phosphatidylserine-dependent manner (Hanayama 
and Nagata, 2005). MFG-E8, which is secreted from mammary 
epithelial cells, promotes the reabsorption of milk fat globules. 
The failure of this process induces mastitis, another case in 
which the inefficient clearance of unnecessary cellular compo-
nents can lead to inflammation. In axon pruning, unnecessary 
or extra axons degenerate, expose phosphatidylserine, and 
are engulfed by glia. However, how the glial phagocytes rec-
ognize the phosphatidylserine on the pruned axons remains to 
be elucidated.Finally, the main reason for the engulfment of dead cells 
is to degrade their intracellular materials before their cellular 
contents are released, which could activate the immune sys-
tem. However, in some cases, phagocytes actively induce 
programmed cell death. For example, macrophages within 
the developing eye induce the programmed cell death of the 
vascular endothelial cells via Wnt ligand (Lobov et al., 2005), 
and phagocyte-induced programmed cell death serves as a 
backup death-inducing system in C. elegans (Reddien and 
Horvitz, 2004). How macrophages are induced to engulf appar-
ently healthy cells is a mystery. The elucidation of this mecha-
nism may help explain hemophagocytic syndrome, in which 
activated macrophages engulf apparently normal red blood 
cells and other cells.
ACkNowlEDgMENTS
We are grateful to all the members of our laboratory at the Graduate School of 
Medicine, Kyoto University. We thank L. Migletta and G. Gray of Clarity Edit-
ing for careful editing of the manuscript. The work in our laboratory was sup-
ported in part by grants-in-aid from the Ministry of Education, Science, and 
Culture of Japan and by the Kyoto University Global COE Program (Center for 
Frontier Medicine).
REFERENCES
Angelillo-Scherrer, A., de Frutos, P., Aparicio, C., Melis, E., Savi, P., Lupu, F., 
Arnout, J., Dewerchin, M., Hoylaerts, M., Herbert, J., et al. (2001). Deficiency 
or inhibition of Gas6 causes platelet dysfunction and protects mice against 
thrombosis. Nat. Med. 7, 215–221.
Angelillo-Scherrer, A., Burnier, L., Flores, N., Savi, P., DeMol, M., Schaeffer, P., 
Herbert, J.M., Lemke, G., Goff, S.P., Matsushima, G.K., et al. (2005). Role of 
Gas6 receptors in platelet signaling during thrombus stabilization and implica-
tions for antithrombotic therapy. J. Clin. Invest. 115, 237–246.
Asano, K., Miwa, M., Miwa, K., Hanayama, R., Nagase, H., Nagata, S., and 
Tanaka, M. (2004). Masking of phosphatidylserine inhibits apoptotic cell en-
gulfment and induces autoantibody production in mice. J. Exp. Med. 200, 
459–467.
Awasaki, T., Tatsumi, R., Takahashi, K., Arai, K., Nakanishi, Y., Ueda, R., and 
Ito, K. (2006). Essential role of the apoptotic cell engulfment genes draper 
and ced-6 in programmed axon pruning during Drosophila metamorphosis. 
Neuron 50, 855–867.
Balasubramanian, K., and Schroit, A.J. (2003). Aminophospholipid asymme-
try: a matter of life and death. Annu. Rev. Physiol. 65, 701–734.
Bassnett, S. (2002). Lens organelle degradation. Exp. Eye Res. 74, 1–6.
Böse, J., Gruber, A.D., Helming, L., Schiebe, S., Wegener, I., Hafner, M., 
Beales, M., Köntgen, F., and Lengeling, A. (2004). The phosphatidylserine re-
ceptor has essential functions during embryogenesis but not in apoptotic cell 
removal. J. Biol. 3, 15.
Botto, M., and Walport, M.J. (2002). C1q, autoimmunity and apoptosis. Im-
munobiology 205, 395–406.
Bournazou, I., Pound, J.D., Duffin, R., Bournazos, S., Melville, L.A., Brown, 
S.B., Rossi, A.G., and Gregory, C.D. (2009). Apoptotic human cells inhibit mi-
gration of granulocytes via release of lactoferrin. J. Clin. Invest. 119, 20–32.
Chang, B., Chen, Y., Zhao, Y., and Bruick, R.K. (2007). JMJD6 is a histone 
arginine demethylase. Science 318, 444–447.
Chasis, J.A., and Mohandas, N. (2008). Erythroblastic islands: niches for 
erythropoiesis. Blood 112, 470–478.
Cho, Y.S., Challa, S., Moquin, D., Genga, R., Ray, T.D., Guildford, M., and 
Chan, F.K. (2009). Phosphorylation-driven assembly of the RIP1-RIP3 com-
plex regulates programmed necrosis and virus-induced inflammation. Cell Cell 140, March 5, 2010 ©2010 Elsevier Inc. 627
137, 1112–1123.
Coleman, M.L., Sahai, E.A., Yeo, M., Bosch, M., Dewar, A., and Olson, M.F. 
(2001). Membrane blebbing during apoptosis results from caspase-mediated 
activation of ROCK I. Nat. Cell Biol. 3, 339–345.
Côté, J.F., and Vuori, K. (2007). GEF what? Dock180 and related proteins help 
Rac to polarize cells in new ways. Trends Cell Biol. 17, 383–393.
D’Cruz, D.P., Khamashta, M.A., and Hughes, G.R. (2007). Systemic lupus ery-
thematosus. Lancet 369, 587–596.
Darland-Ransom, M., Wang, X., Sun, C.L., Mapes, J., Gengyo-Ando, K., Mi-
tani, S., and Xue, D. (2008). Role of C. elegans TAT-1 protein in maintaining 
plasma membrane phosphatidylserine asymmetry. Science 320, 528–531.
Elliott, M.R., Chekeni, F.B., Trampont, P.C., Lazarowski, E.R., Kadl, A., Walk, 
S.F., Park, D., Woodson, R.I., Ostankovich, M., Sharma, P., et al. (2009). 
Nucleotides released by apoptotic cells act as a find-me signal to promote 
phagocytic clearance. Nature 461, 282–286.
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, 
S. (1998). A caspase-activated DNase that degrades DNA during apoptosis, 
and its inhibitor ICAD. Nature 391, 43–50.
Evans, C.J., and Aguilera, R.J. (2003). DNase II: genes, enzymes and function. 
Gene 322, 1–15.
Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., and 
Henson, P.M. (1992). Exposure of phosphatidylserine on the surface of apop-
totic lymphocytes triggers specific recognition and removal by macrophages. 
J. Immunol. 148, 2207–2216.
Fadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A., and 
Henson, P.M. (2000). A receptor for phosphatidylserine-specific clearance of 
apoptotic cells. Nature 405, 85–90.
Fadok, V.A., Bratton, D.L., Guthrie, L., and Henson, P.M. (2001). Differential ef-
fects of apoptotic versus lysed cells on macrophage production of cytokines: 
role of proteases. J. Immunol. 166, 6847–6854.
Feldmann, M. (2002). Development of anti-TNF therapy for rheumatoid arthri-
tis. Nat. Rev. Immunol. 2, 364–371.
Florey, O., and Haskard, D.O. (2009). Sphingosine 1-phosphate enhances Fc 
gamma receptor-mediated neutrophil activation and recruitment under flow 
conditions. J. Immunol. 183, 2330–2336.
Gaipl, U.S., Kuhn, A., Sheriff, A., Munoz, L.E., Franz, S., Voll, R.E., Kalden, 
J.R., and Herrmann, M. (2006). Clearance of apoptotic cells in human SLE. 
Curr. Dir. Autoimmun. 9, 173–187.
Gude, D.R., Alvarez, S.E., Paugh, S.W., Mitra, P., Yu, J., Griffiths, R., Barbour, 
S.E., Milstien, S., and Spiegel, S. (2008). Apoptosis induces expression of 
sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-
get-me” signal. FASEB J. 22, 2629–2638.
Hamon, Y., Trompier, D., Ma, Z., Venegas, V., Pophillat, M., Mignotte, V., Zhou, 
Z., and Chimini, G. (2006). Cooperation between engulfment receptors: the 
case of ABCA1 and MEGF10. PLoS ONE 1, e120.
Hanayama, R., and Nagata, S. (2005). Impaired involution of mammary glands 
in the absence of milk fat globule EGF factor 8. Proc. Natl. Acad. Sci. USA 
102, 16886–16891.
Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A., and Naga-
ta, S. (2002). Identification of a factor that links apoptotic cells to phagocytes. 
Nature 417, 182–187.
Hanayama, R., Tanaka, M., Miyasaka, K., Aozasa, K., Koike, M., Uchiyama, Y., 
and Nagata, S. (2004). Autoimmune disease and impaired uptake of apoptotic 
cells in MFG-E8-deficient mice. Science 304, 1147–1150.
Harris, E.N., Weigel, J.A., and Weigel, P.H. (2008). The human hyaluronan re-
ceptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for 
heparin. J. Biol. Chem. 283, 17341–17350.
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., and Wang, X. (2009). 
Receptor interacting protein kinase-3 determines cellular necrotic response to 628 Cell 140, March 5, 2010 ©2010 Elsevier Inc.TNF-alpha. Cell 137, 1100–1111.
Herlands, R.A., Christensen, S.R., Sweet, R.A., Hershberg, U., and Shlom-
chik, M.J. (2008). T cell-independent and toll-like receptor-dependent anti-
gen-driven activation of autoreactive B cells. Immunity 29, 249–260.
Honda, K., Takaoka, A., and Taniguchi, T. (2006). Type I interferon [corrected] 
gene induction by the interferon regulatory factor family of transcription fac-
tors. Immunity 25, 349–360.
Ichimura, T., Asseldonk, E.J., Humphreys, B.D., Gunaratnam, L., Duffield, 
J.S., and Bonventre, J.V. (2008). Kidney injury molecule-1 is a phosphatidyl-
serine receptor that confers a phagocytic phenotype on epithelial cells. J. 
Clin. Invest. 118, 1657–1668.
Ikehara, S. (2002). Bone marrow transplantation: a new strategy for intrac-
table diseases. Drugs Today (Barc) 38, 103–111.
Kawane, K., Fukuyama, H., Kondoh, G., Takeda, J., Ohsawa, Y., Uchiyama, Y., 
and Nagata, S. (2001). Requirement of DNase II for definitive erythropoiesis in 
the mouse fetal liver. Science 292, 1546–1549.
Kawane, K., Fukuyama, H., Yoshida, H., Nagase, H., Ohsawa, Y., Uchiyama, 
Y., Okada, K., Iida, T., and Nagata, S. (2003). Impaired thymic development 
in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 4, 
138–144.
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yo-
shikawa, H., and Nagata, S. (2006). Chronic polyarthritis caused by mam-
malian DNA that escapes from degradation in macrophages. Nature 443, 
998–1002.
Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, 
D., and Kollias, G. (1991). Transgenic mice expressing human tumour necrosis 
factor: a predictive genetic model of arthritis. EMBO J. 10, 4025–4031.
Kerr, J.F., Wyllie, A.H., and Currie, A.R. (1972). Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 
26, 239–257.
Kim, S.J., Gershov, D., Ma, X., Brot, N., and Elkon, K.B. (2002). I-PLA(2) acti-
vation during apoptosis promotes the exposure of membrane lysophosphati-
dylcholine leading to binding by natural immunoglobulin M antibodies and 
complement activation. J. Exp. Med. 196, 655–665.
Kitano, M., Nakaya, M., Nakamura, T., Nagata, S., and Matsuda, M. (2008). 
Imaging of Rab5 activity identifies essential regulators for phagosome matu-
ration. Nature 453, 241–245.
Krahling, S., Callahan, M.K., Williamson, P., and Schlegel, R.A. (1999). Expo-
sure of phosphatidylserine is a general feature in the phagocytosis of apop-
totic lymphocytes by macrophages. Cell Death Differ. 6, 183–189.
Krammer, P.H. (2000). CD95’s deadly mission in the immune system. Nature 
407, 789–795.
Kranich, J., Krautler, N.J., Heinen, E., Polymenidou, M., Bridel, C., Schild-
knecht, A., Huber, C., Kosco-Vilbois, M.H., Zinkernagel, R., Miele, G., and 
Aguzzi, A. (2008). Follicular dendritic cells control engulfment of apoptotic 
bodies by secreting Mfge8. J. Exp. Med. 205, 1293–1302.
Kroemer, G., and Levine, B. (2008). Autophagic cell death: the story of a mis-
nomer. Nat. Rev. Mol. Cell Biol. 9, 1004–1010.
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E.S., Baeh-
recke, E.H., Blagosklonny, M.V., El-Deiry, W.S., Golstein, P., Green, D.R., et 
al; Nomenclature Committee on Cell Death 2009. (2009). Classification of 
cell death: recommendations of the Nomenclature Committee on Cell Death 
2009. Cell Death Differ. 16, 3–11.
Kuchroo, V.K., Umetsu, D.T., DeKruyff, R.H., and Freeman, G.J. (2003). The 
TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 
3, 454–462.
Kunisaki, Y., Masuko, S., Noda, M., Inayoshi, A., Sanui, T., Harada, M., 
Sasazuki, T., and Fukui, Y. (2004). Defective fetal liver erythropoiesis and T 
lymphopoiesis in mice lacking the phosphatidylserine receptor. Blood 103, 
3362–3364.
Lauber, K., Bohn, E., Kröber, S.M., Xiao, Y.J., Blumenthal, S.G., Lindemann, 
R.K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003). Apoptotic 
cells induce migration of phagocytes via caspase-3-mediated release of a 
lipid attraction signal. Cell 113, 717–730.
Lecut, C., Frederix, K., Johnson, D.M., Deroanne, C., Thiry, M., Faccinetto, 
C., Marée, R., Evans, R.J., Volders, P.G., Bours, V., and Oury, C. (2009). P2X1 
ion channels promote neutrophil chemotaxis through Rho kinase activation. 
J. Immunol. 183, 2801–2809.
Li, M.O., Sarkisian, M.R., Mehal, W.Z., Rakic, P., and Flavell, R.A. (2003). 
Phosphatidylserine receptor is required for clearance of apoptotic cells. Sci-
ence 302, 1560–1563.
Lian, X., Yan, C., Yang, L., Xu, Y., and Du, H. (2004). Lysosomal acid lipase 
deficiency causes respiratory inflammation and destruction in the lung. Am. J. 
Physiol. Lung Cell. Mol. Physiol. 286, L801–L807.
Lippens, S., Denecker, G., Ovaere, P., Vandenabeele, P., and Declercq, W. 
(2005). Death penalty for keratinocytes: apoptosis versus cornification. Cell 
Death Differ. 12 (Suppl 2), 1497–1508.
Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a heterodimeric pro-
tein that functions downstream of caspase-3 to trigger DNA fragmentation 
during apoptosis. Cell 89, 175–184.
Lobov, I.B., Rao, S., Carroll, T.J., Vallance, J.E., Ito, M., Ondr, J.K., Kurup, S., 
Glass, D.A., Patel, M.S., Shu, W., et al. (2005). WNT7b mediates macrophage-
induced programmed cell death in patterning of the vasculature. Nature 437, 
417–421.
Lockshin, R.A., and Zakeri, Z. (2001). Programmed cell death and apoptosis: 
origins of the theory. Nat. Rev. Mol. Cell Biol. 2, 545–550.
Lüthi, A.U., and Martin, S.J. (2007). The CASBAH: a searchable database of 
caspase substrates. Cell Death Differ. 14, 641–650.
Martin, S.J., Finucane, D.M., Amarante-Mendes, G.P., O’Brien, G.A., and 
Green, D.R. (1996). Phosphatidylserine externalization during CD95-induced 
apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. 
Biol. Chem. 271, 28753–28756.
Migita, K., Tanaka, F., Yamasaki, S., Shibatomi, K., Ida, H., Kawakami, A., 
Aoyagi, T., Kawabe, Y., and Eguchi, K. (2001). Regulation of rheumatoid syn-
oviocyte proliferation by endogenous p53 induction. Clin. Exp. Immunol. 126, 
334–338.
Miyake, Y., Asano, K., Kaise, H., Uemura, M., Nakayama, M., and Tanaka, M. 
(2007). Critical role of macrophages in the marginal zone in the suppression 
of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 
117, 2268–2278.
Miyanishi, M., Tada, K., Koike, M., Uchiyama, Y., Kitamura, T., and Nagata, S. 
(2007). Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 
435–439.
Miyasaka, K., Hanayama, R., Tanaka, M., and Nagata, S. (2004). Expression 
of milk fat globule epidermal growth factor 8 in immature dendritic cells for 
engulfment of apoptotic cells. Eur. J. Immunol. 34, 1414–1422.
Mori, K., Kanemura, Y., Fujikawa, H., Nakano, A., Ikemoto, H., Ozaki, I., Mat-
sumoto, T., Tamura, K., Yokota, M., and Arita, N. (2002). Brain-specific an-
giogenesis inhibitor 1 (BAI1) is expressed in human cerebral neuronal cells. 
Neurosci. Res. 43, 69–74.
Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355–365.
Nakano, T., Ishimoto, Y., Kishino, J., Umeda, M., Inoue, K., Nagata, K., Ohashi, 
K., Mizuno, K., and Arita, H. (1997). Cell adhesion to phosphatidylserine me-
diated by a product of growth arrest-specific gene 6. J. Biol. Chem. 272, 
29411–29414.
Nakaya, M., Tanaka, M., Okabe, Y., Hanayama, R., and Nagata, S. (2006). 
Opposite effects of rho family GTPases on engulfment of apoptotic cells by 
macrophages. J. Biol. Chem. 281, 8836–8842.
Nakaya, M., Kitano, M., Matsuda, M., and Nagata, S. (2008). Spatiotemporal 
activation of Rac1 for engulfment of apoptotic cells. Proc. Natl. Acad. Sci. 
USA 105, 9198–9203.Nakayama, M., Akiba, H., Takeda, K., Kojima, Y., Hashiguchi, M., Azuma, M., 
Yagita, H., and Okumura, K. (2009). Tim-3 mediates phagocytosis of apop-
totic cells and cross-presentation. Blood 113, 3821–3830.
Neufeld, E.F. (1991). Lysosomal storage diseases. Annu. Rev. Biochem. 60, 
257–280.
Nonaka, H., Tanaka, M., Suzuki, K., and Miyajima, A. (2007). Development of 
murine hepatic sinusoidal endothelial cells characterized by the expression of 
hyaluronan receptors. Dev. Dyn. 236, 2258–2267.
Oberst, A., Bender, C., and Green, D.R. (2008). Living with death: the evolu-
tion of the mitochondrial pathway of apoptosis in animals. Cell Death Differ. 
15, 1139–1146.
Ogden, C.A., Kowalewski, R., Peng, Y., Montenegro, V., and Elkon, K.B. 
(2005). IGM is required for efficient complement mediated phagocytosis of 
apoptotic cells in vivo. Autoimmunity 38, 259–264.
Ohsumi, Y. (2001). Molecular dissection of autophagy: two ubiquitin-like sys-
tems. Nat. Rev. Mol. Cell Biol. 2, 211–216.
Okabe, Y., Kawane, K., Akira, S., Taniguchi, T., and Nagata, S. (2005). Toll-like 
receptor-independent gene induction program activated by mammalian DNA 
escaped from apoptotic DNA degradation. J. Exp. Med. 202, 1333–1339.
Okabe, Y., Sano, T., and Nagata, S. (2009). Regulation of the innate immune 
response by threonine-phosphatase of Eyes absent. Nature 460, 520–524.
Oldenborg, P.A., Zheleznyak, A., Fang, Y.F., Lagenaur, C.F., Gresham, H.D., 
and Lindberg, F.P. (2000). Role of CD47 as a marker of self on red blood cells. 
Science 288, 2051–2054.
Ow, Y.P., Green, D.R., Hao, Z., and Mak, T.W. (2008). Cytochrome c: functions 
beyond respiration. Nat. Rev. Mol. Cell Biol. 9, 532–542.
Park, D., Tosello-Trampont, A.C., Elliott, M.R., Lu, M., Haney, L.B., Ma, Z., 
Klibanov, A.L., Mandell, J.W., and Ravichandran, K.S. (2007). BAI1 is an en-
gulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac 
module. Nature 450, 430–434.
Park, S.Y., Jung, M.Y., Kim, H.J., Lee, S.J., Kim, S.Y., Lee, B.H., Kwon, T.H., 
Park, R.W., and Kim, I.S. (2008). Rapid cell corpse clearance by stabilin-2, a 
membrane phosphatidylserine receptor. Cell Death Differ. 15, 192–201.
Park, D., Hochreiter-Hufford, A., and Ravichandran, K.S. (2009). The phos-
phatidylserine receptor TIM-4 does not mediate direct signaling. Curr. Biol. 
19, 346–351.
Peter, C., Waibel, M., Radu, C.G., Yang, L.V., Witte, O.N., Schulze-Osthoff, 
K., Wesselborg, S., and Lauber, K. (2008). Migration to apoptotic “find-me” 
signals is mediated via the phagocyte receptor G2A. J. Biol. Chem. 283, 
5296–5305.
Potter, P.K., Cortes-Hernandez, J., Quartier, P., Botto, M., and Walport, M.J. 
(2003). Lupus-prone mice have an abnormal response to thioglycolate and an 
impaired clearance of apoptotic cells. J. Immunol. 170, 3223–3232.
Prasad, D., Rothlin, C.V., Burrola, P., Burstyn-Cohen, T., Lu, Q., Garcia de 
Frutos, P., and Lemke, G. (2006). TAM receptor function in the retinal pigment 
epithelium. Mol. Cell. Neurosci. 33, 96–108.
Ravichandran, K.S., and Lorenz, U. (2007). Engulfment of apoptotic cells: sig-
nals for a good meal. Nat. Rev. Immunol. 7, 964–974.
Reddien, P.W., and Horvitz, H.R. (2004). The engulfment process of pro-
grammed cell death in caenorhabditis elegans. Annu. Rev. Cell Dev. Biol. 20, 
193–221.
Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B., and Lemke, G. (2007). 
TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 
131, 1124–1136.
Rumore, P.M., and Steinman, C.R. (1990). Endogenous circulating DNA in 
systemic lupus erythematosus. Occurrence as multimeric complexes bound 
to histone. J. Clin. Invest. 86, 69–74.
Sahu, S.K., Gummadi, S.N., Manoj, N., and Aradhyam, G.K. (2007). Phospho-
lipid scramblases: an overview. Arch. Biochem. Biophys. 462, 103–114.Cell 140, March 5, 2010 ©2010 Elsevier Inc. 629
Sakahira, H., Enari, M., and Nagata, S. (1998). Cleavage of CAD inhibitor in 
CAD activation and DNA degradation during apoptosis. Nature 391, 96–99.
Sakahira, H., Iwamatsu, A., and Nagata, S. (2000). Specific chaperone-like 
activity of inhibitor of caspase-activated DNase for caspase-activated DNase. 
J. Biol. Chem. 275, 8091–8096.
Sakahira, H., Takemura, Y., and Nagata, S. (2001). Enzymatic active site of 
caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD. Arch. 
Biochem. Biophys. 388, 91–99.
Samejima, K., Tone, S., and Earnshaw, W.C. (2001). CAD/DFF40 nuclease is 
dispensable for high molecular weight DNA cleavage and stage I chromatin 
condensation in apoptosis. J. Biol. Chem. 276, 45427–45432.
Schlegel, R.A., and Williamson, P. (2007). P.S. to PS (phosphatidylserine)—
pertinent proteins in apoptotic cell clearance. Sci. STKE 2007, pe57.
Scott, R.S., McMahon, E.J., Pop, S.M., Reap, E.A., Caricchio, R., Cohen, 
P.L., Earp, H.S., and Matsushima, G.K. (2001). Phagocytosis and clearance of 
apoptotic cells is mediated by MER. Nature 411, 207–211.
Sebbagh, M., Renvoizé, C., Hamelin, J., Riché, N., Bertoglio, J., and Bréard, J. 
(2001). Caspase-3-mediated cleavage of ROCK I induces MLC phosphoryla-
tion and apoptotic membrane blebbing. Nat. Cell Biol. 3, 346–352.
Shakhov, A.N., Rybtsov, S., Tumanov, A.V., Shulenin, S., Dean, M., Kuprash, 
D.V., and Nedospasov, S.A. (2004). SMUCKLER/TIM4 is a distinct member of 
TIM family expressed by stromal cells of secondary lymphoid tissues and as-
sociated with lymphotoxin signaling. Eur. J. Immunol. 34, 494–503.
Strasser, A., Jost, P.J., and Nagata, S. (2009). The many roles of FAS receptor 
signaling in the immune system. Immunity 30, 180–192.
Su, H.P., Nakada-Tsukui, K., Tosello-Trampont, A.C., Li, Y., Bu, G., Henson, 
P.M., and Ravichandran, K.S. (2002). Interaction of CED-6/GULP, an adapt-
er protein involved in engulfment of apoptotic cells with CED-1 and CD91/
low density lipoprotein receptor-related protein (LRP). J. Biol. Chem. 277, 
11772–11779.
Susin, S.A., Daugas, E., Ravagnan, L., Samejima, K., Zamzami, N., Loeffler, 
M., Costantini, P., Ferri, K.F., Irinopoulou, T., Prévost, M.C., et al. (2000). Two 
distinct pathways leading to nuclear apoptosis. J. Exp. Med. 192, 571–580.
Suzuki, M., Sugimoto, Y., Ohsaki, Y., Ueno, M., Kato, S., Kitamura, Y., Ho-
sokawa, H., Davies, J.P., Ioannou, Y.A., Vanier, M.T., et al. (2007). Endosomal 
accumulation of Toll-like receptor 4 causes constitutive secretion of cytok-
ines and activation of signal transducers and activators of transcription in 
Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell 
activation in the NPC brain. J. Neurosci. 27, 1879–1891.
Taberner, M., Scott, K.F., Weininger, L., Mackay, C.R., and Rolph, M.S. (2005). 
Overlapping gene expression profiles in rheumatoid fibroblast-like synovio-
cytes induced by the proinflammatory cytokines interleukin-1 beta and tumor 
necrosis factor. Inflamm. Res. 54, 10–16.
Tada, K., Tanaka, M., Hanayama, R., Miwa, K., Shinohara, A., Iwamatsu, A., 
and Nagata, S. (2003). Tethering of apoptotic cells to phagocytes through 
binding of CD47 to Src homology 2 domain-bearing protein tyrosine phos-
phatase substrate-1. J. Immunol. 171, 5718–5726.
Tanaka, Y., and Schroit, A.J. (1983). Insertion of fluorescent phosphatidylser-
ine into the plasma membrane of red blood cells. Recognition by autologous 
macrophages. J. Biol. Chem. 258, 11335–11343.
Timmer, J.C., and Salvesen, G.S. (2007). Caspase substrates. Cell Death Dif-
fer. 14, 66–72.
Trouw, L.A., Blom, A.M., and Gasque, P. (2008). Role of complement and 
complement regulators in the removal of apoptotic cells. Mol. Immunol. 45, 
1199–1207.
Truman, L.A., Ogden, C.A., Howie, S.E., and Gregory, C.D. (2004). Mac-
rophage chemotaxis to apoptotic Burkitt’s lymphoma cells in vitro: role of 630 Cell 140, March 5, 2010 ©2010 Elsevier Inc.CD14 and CD36. Immunobiology 209, 21–30.
Truman, L.A., Ford, C.A., Pasikowska, M., Pound, J.D., Wilkinson, S.J., Dumi-
triu, I.E., Melville, L., Melrose, L.A., Ogden, C.A., Nibbs, R., et al. (2008). CX-
3CL1/fractalkine is released from apoptotic lymphocytes to stimulate mac-
rophage chemotaxis. Blood 112, 5026–5036.
Tsujimoto, Y., and Shimizu, S. (2005). Another way to die: autophagic pro-
grammed cell death. Cell Death Differ. 12 (Suppl 2), 1528–1534.
Uematsu, S., and Akira, S. (2007). Toll-like receptors and Type I interferons. J. 
Biol. Chem. 282, 15319–15323.
Umetsu, S.E., Lee, W.L., McIntire, J.J., Downey, L., Sanjanwala, B., Akbari, 
O., Berry, G.J., Nagumo, H., Freeman, G.J., Umetsu, D.T., and DeKruyff, R.H. 
(2005). TIM-1 induces T cell activation and inhibits the development of periph-
eral tolerance. Nat. Immunol. 6, 447–454.
van den Eijnde, S.M., Boshart, L., Baehrecke, E.H., De Zeeuw, C.I., Reute-
lingsperger, C.P., and Vermeij-Keers, C. (1998). Cell surface exposure of phos-
phatidylserine during apoptosis is phylogenetically conserved. Apoptosis 3, 
9–16.
Venegas, V., and Zhou, Z. (2007). Two alternative mechanisms that regulate 
the presentation of apoptotic cell engulfment signal in Caenorhabditis ele-
gans. Mol. Biol. Cell 18, 3180–3192.
Wang, X., Wu, Y.C., Fadok, V.A., Lee, M.C., Gengyo-Ando, K., Cheng, L.C., 
Ledwich, D., Hsu, P.K., Chen, J.Y., Chou, B.K., et al. (2003). Cell corpse en-
gulfment mediated by C. elegans phosphatidylserine receptor through CED-5 
and CED-12. Science 302, 1563–1566.
Ward, P.P., Mendoza-Meneses, M., Cunningham, G.A., and Conneely, O.M. 
(2003). Iron status in mice carrying a targeted disruption of lactoferrin. Mol. 
Cell. Biol. 23, 178–185.
Woo, E.-J., Kim, Y.-G., Kim, M.-S., Han, W.-D., Shin, S., Robinson, H., Park, 
S.-Y., and Oh, B.-H. (2004). Structural mechanism for inactivation and activa-
tion of CAD/DFF40 in the apoptotic pathway. Mol. Cell 14, 531–539.
Wyllie, A.H. (1980). Glucocorticoid-induced thymocyte apoptosis is associ-
ated with endogenous endonuclease activation. Nature 284, 555–556.
Xiong, W., Chen, Y., Wang, H., Wang, H., Wu, H., Lu, Q., and Han, D. (2008). 
Gas6 and the Tyro 3 receptor tyrosine kinase subfamily regulate the phago-
cytic function of Sertoli cells. Reproduction 135, 77–87.
Yamaguchi, H., Takagi, J., Miyamae, T., Yokota, S., Fujimoto, T., Nakamura, 
S., Ohshima, S., Naka, T., and Nagata, S. (2008). Milk fat globule EGF factor 8 
in the serum of human patients of systemic lupus erythematosus. J. Leukoc. 
Biol. 83, 1300–1307.
Yokota, S., Imagawa, T., Mori, M., Miyamae, T., Aihara, Y., Takei, S., Iwata, N., 
Umebayashi, H., Murata, T., Miyoshi, M., et al. (2008). Efficacy and safety of 
tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a ran-
domised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet 
371, 998–1006.
Yoshida, H., Kawane, K., Koike, M., Mori, Y., Uchiyama, Y., and Nagata, S. 
(2005a). Phosphatidylserine-dependent engulfment by macrophages of nu-
clei from erythroid precursor cells. Nature 437, 754–758.
Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H., and Nagata, S. (2005b). 
Lethal anemia caused by interferon-beta produced in mouse embryos carry-
ing undigested DNA. Nat. Immunol. 6, 49–56.
Zhang, H.G., Hyde, K., Page, G.P., Brand, J.P., Zhou, J., Yu, S., Allison, D.B., 
Hsu, H.C., and Mountz, J.D. (2004). Novel tumor necrosis factor alpha-regu-
lated genes in rheumatoid arthritis. Arthritis Rheum. 50, 420–431.
Züllig, S., Neukomm, L.J., Jovanovic, M., Charette, S.J., Lyssenko, N.N., 
Halleck, M.S., Reutelingsperger, C.P., Schlegel, R.A., and Hengartner, M.O. 
(2007). Aminophospholipid translocase TAT-1 promotes phosphatidylserine 
exposure during C. elegans apoptosis. Curr. Biol. 17, 994–999.
